መነሻ › የሳንባ ካንሰር › Oklahoma › Oklahoma City
በOklahoma City፣ OK ለየሳንባ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለየሳንባ ካንሰር የሚደረጉ 19 ጥናቶች በOklahoma City እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ተሳታዮችን በመፈለግ ላይደረጃ 3
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
- Integris Cancer Institute of Oklahoma, Oklahoma City
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of Oklahoma, Oklahoma City
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
- Mercy Hospital Oklahoma City, Oklahoma City
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Mercy Hospital Oklahoma City, Oklahoma City
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- University of Oklahoma Health Sciences Center, Oklahoma City
- Integris Cancer Institute of Oklahoma, Oklahoma City
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
ተሳታዮችን በመፈለግ ላይደረጃ 3
- University of Oklahoma Health Sciences Center, Oklahoma City
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Hightower Clinical, LLC ( Site 0084), Oklahoma City
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- INTEGRIS Cancer Institute of Oklahoma, Oklahoma City
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of Oklahoma, Oklahoma City
Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
- Site 101, Oklahoma City
The Vanguard Study: Testing a New Way to Screen for Cancer
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
ተሳታዮችን በመፈለግ ላይደረጃ 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Xencor Investigative Site, Oklahoma City
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Sarah Cannon Research Institute University of Oklahoma, Oklahoma City
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
- University of Oklahoma Health Sciences Center, Oklahoma City
- Integris Southwest Medical Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Hightower Clinical, Oklahoma City
በሌሎች ከተሞች ለየሳንባ ካንሰር የሚደረጉ ጥናቶች
- Houston, TX78 ጥናቶች
- Boston, MA62 ጥናቶች
- New York City, NY60 ጥናቶች
- Los Angeles, CA45 ጥናቶች
- Washington, DC41 ጥናቶች
- Arlington, VA41 ጥናቶች
- Chicago, IL41 ጥናቶች
- Nashville, TN40 ጥናቶች
- Baltimore, MD40 ጥናቶች
- St. Louis, MO39 ጥናቶች
- Columbus, OH37 ጥናቶች
- Philadelphia, PA36 ጥናቶች
በOklahoma City ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር28 ጥናቶች
- የእንቁላል ካንሰር28 ጥናቶች
- የኤንዶሜትሪየም ካንሰር25 ጥናቶች
- የኮሎሬክታል ካንሰር22 ጥናቶች
- የፕሮስቴት ካንሰር21 ጥናቶች
- የጡንቻ ካንሰር17 ጥናቶች
- Metastatic Cancer15 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)14 ጥናቶች
- አኩት ማይሎይድ ሊውኬሚያ14 ጥናቶች
- የራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ13 ጥናቶች
- የፓንክሪያስ ካንሰር11 ጥናቶች
- የሽንት ፊኛ ካንሰር11 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።